ライフサイエンスコーパス: written informed consent

1 randomly assigned to treatment who provided written informed consent).

2 ion between 10 and 11 October 2015 following written informed consent.

3 rns, and practical issues in recruitment and written informed consent.

4 btained, and all recruited subjects provided written informed consent.

5 the patients and the control group provided written informed consent.

6 review board-approved and participants gave written informed consent.

7 tional government, and all participants gave written informed consent.

8 asthmatic and four healthy individuals gave written informed consent.

9 y, the ethical committee did not require any written informed consent.

10 iagnosed with paracetamol overdose, and gave written informed consent.

11 ocal ethics committee, and all subjects gave written informed consent.

12 Participants (or parents) gave written informed consent.

13 ging of the breast at 7 T, all patients gave written informed consent.

14 with US, performed with ethical approval and written informed consent.

15 e included in this study after they provided written informed consent.

16 utional review board and patients gave their written informed consent.

17 thics committee approval, and all women gave written informed consent.

18 board approval for this study and patients' written informed consent.

19 Participants provided written informed consent.

20 ol (number 1225/2012), and all patients gave written informed consent.

21 lish, and all participating parents provided written informed consent.

22 ars) (P = .76) were enrolled after obtaining written informed consent.

23 ew board approval, and all participants gave written informed consent.

24 tutional review board, and all subjects gave written informed consent.

25 ttee, and all patients or their parents gave written informed consent.

26 with institutional review board approval and written informed consent.

27 oved, HIPAA-compliant prospective study with written informed consent.

28 ethics committee, all participants provided written informed consent.

29 ics were approved, and participants provided written informed consent.

30 All subjects gave their written informed consent.

31 ision-making and either formal discussion or written informed consent.

32 ard of each center and participants provided written informed consent.

33 tutional review board, and all patients gave written informed consent.

34 red over 5 years in 91 subjects who provided written informed consent.

35 iew committee approved this study and waived written informed consent.

36 tional nature of the procedures and provided written informed consent.

37 onal review board, and all patients provided written informed consent.

38 oval was obtained, and all subjects provided written informed consent.

39 , and 34 patients were examined after giving written informed consent.

40 oved the protocol, and all patients provided written informed consent.

41 ommittee approval, and all participants gave written informed consent.

42 oval was obtained, and all patients provided written informed consent.

43 board approved the study; all subjects gave written informed consent.

44 is study was obtained, and each patient gave written informed consent.

45 ethical committee; each participant provided written informed consent.

46 oard approval, and all participants provided written informed consent.

47 participating centers, and patients provided written informed consent.

48 risk, not warranting extensive discussion or written informed consent.

49 dical ethics committee and all subjects gave written informed consent.

50 Participating women gave written informed consent.

51 regional ethics committee; all patients gave written informed consent.

52 roved this retrospective analysis and waived written informed consent.

53 review board, and all participants provided written informed consent.

54 tee approved the study and all patients gave written informed consent.

55 clinical site, and all participants provided written informed consent.

56 arch ethics committee, and participants gave written informed consent.

57 ccording to a HIPAA-compliant protocol, with written informed consent.

58 hics approval, and all participants provided written informed consent.

59 es approved the study; all participants gave written informed consent.

60 Ethics Committee, and all subjects gave full written informed consent.

61 ics committee, and all participants provided written informed consent.

62 onal review board, and all participants gave written informed consent.

63 e approved this study, and all subjects gave written informed consent.

64 All volunteers provided written informed consent.

65 HIPAA compliance, and all patients provided written informed consent.

66 prior to study initiation, and patients gave written informed consent.

67 tutional review board, and all subjects gave written informed consent.

68 he study after ethics committee approval and written informed consent.

69 the institutional ethical review board, with written informed consent.

70 ethics committee, and all patients provided written informed consent.

71 ts, and/or their legal representatives, gave written informed consent.

72 review board approved; all patients provided written informed consent.

73 his study and waived the need for individual written informed consent.

74 All subjects gave written informed consent.

75 pective multicenter study was performed with written informed consent.

76 onal ethics committee, and all patients gave written informed consent.

77 pproval were received, as was each patient's written informed consent.

78 rd approved the study, and all subjects gave written informed consent.

79 rd approved the study, and all patients gave written informed consent.

80 between October 10th and 11th 2015 following written informed consent.

81 All patients provided written informed consent.

82 review board approval and all patients gave written informed consent.

83 Patients gave written informed consent.

84 with institutional review board approval and written informed consent.

85 s obtained for this study; all patients gave written informed consent.

86 icenter study, and all participants provided written informed consent.

87 ears; range, 70.4-101.2 years) who had given written informed consent.

88 and Declaration Good Clinical Practice with written informed consent.

89 tional government, and all participants gave written informed consent.

90 iew board-approved study after they provided written informed consent.

91 All subjects provided written informed consent.

92 and Accountability Act compliant study with written informed consent.

93 ethics committee, and all participants gave written informed consent.

94 ved this retrospective study, with waiver of written informed consent.

95 Participants gave written informed consent.

96 All patients gave written informed consent.

97 ocal ethics committee, and all subjects gave written informed consent.

98 oved the study and all participants provided written informed consent.

99 approved by institutional review boards with written informed consent.

100 All participants provided written informed consent.

101 ethics committee, and all participants gave written informed consent.

102 review boards, and all participants provided written, informed consent.

103 rd-approved prospective study, with parental written informed consent, 13-MHz 3D three-dimensional US

104 With institutional review board approval and written informed consent, 18 right-handed, cognitively h

105 After written informed consent, 221 consecutive patients >/= 5

106 the institutional review board and patients' written informed consent, 531 women with unilateral inva

107 Following written informed consent, a data set of 36 281 mammogram

108 iew board-approved, prospectively conducted (written informed consent acquired), cross-sectional stud

109 olunteers (mean age 31, five were male) gave written informed consent and both of their IONs were ima

110 years; 78% [29] men, 22% [eight] women) gave written informed consent and completed a questionnaire t

111 Materials and Methods Written informed consent and institutional ethics commit

112 Participants gave written informed consent and the study was approved by t

113 secondary progressive MS ) patients provided written informed consent and underwent 3-T MR imaging.

114 diation therapy for prostate cancer provided written informed consent and were enrolled in a prospect

115 4 groups (range, 60.3% to 71.5%) recommended written informed consent, and personal preferences were

116 All subjects provided written informed consent, and the local institutional re

117 Participants gave written informed consent, and the Norwegian committee fo

118 Materials and Methods All subjects provided written informed consent, and the protocol was approved

119 All study participants gave written informed consent, and the study was approved by

120 his retrospective study, all patients signed written informed consent as a requisite to undergo PET/C

121 ts or guardians of all participants provided written informed consent at the time of enrollment.

122 oards approved the study and donors provided written informed consent before death.

123 Participants provide written informed consent before the MR imaging examinati

124 All patients provided written informed consent before the study; the need to o

125 f research that would require disclosure and written informed consent, but data are lacking on the vi

126 nts in the extended follow-up provided their written informed consent (data cutoff: December 31, 2016

127 consent for participation for any minors and written informed consent for any participants that were

128 Methods: All patients gave written informed consent for further utility of the biol

129 review of stem cell donors who had provided written informed consent for stem cell donation and use

130 Patients gave written informed consent for study enrollment, including

131 Patients gave their written informed consent for study enrollment.

132 Written informed consent for study participation was obt

133 All patients provided written informed consent for study participation, the ab

134 Written informed consent for the percutaneous procedure

135 All patients gave written informed consent for the scientific analysis of

136 All subjects provided written informed consent for this HIPAA-compliant and in

137 , aged 60-75 years, 46% (138) male, who gave written informed consent, for 4-year periods following r

138 hods Institutional review board approval and written informed consent from all participants were obta

139 ocal ethics committees on human studies, and written informed consent from all patients was obtained

140 Institutional review board approval and written informed consent from all patients were obtained

141 nstitutional ethics committee approval, with written informed consent from all patients.

142 approved by institutional review board, with written informed consent from all patients.

143 cal ethical committees on human studies, and written informed consent from all subjects was obtained

144 Institutional review board approval and written informed consent from all subjects were obtained

145 institutional review board approval and with written informed consent from all subjects.

146 l ethical committee was obtained, as well as written informed consent from each participant.

147 with research ethics committee approval and written informed consent from each subject, were include

148 from the institutional ethics committee and written informed consent from the patients, 37 patients

149 Materials and Methods Written informed consent in this institutional review bo

150 board-approved HIPAA-compliant protocol with written informed consent, IVIM and DT imaging were perfo

151 tional review board-approved study, with the written informed consent of all patients, two-dimensiona

152 Institutional review board approval and written informed consent of five volunteers and 33 patie

153 Written informed consent of the original study permitted

154 2008, and July 31, 2012, 4512 women provided written informed consent of whom 3977 (88%) were eligibl

155 labour, aged 15 years or older, and provided written informed consent on behalf of themselves and the

156 Patients provided written informed consent, or, at select sites, there was

157 Most of the public favored written informed consent over the most widely advocated

158 We obtained written informed consent postmortem from the next of kin

159 ubjects and their legal representatives gave written informed consent prior to data collection.

160 ation of Helsinki, and all patients provided written informed consent prior to enrollment.

161 Materials and Methods All patients gave written informed consent prior to inclusion in this inst

162 All patients gave written informed consent prior to their examination.

163 he local ethics committee, and patients gave written informed consent prior to their inclusion in the

164 was 5 weeks, and all men were enrolled with written informed consent prior to treatment.

165 All patients provided written informed consent prior to undergoing any study-r

166 review board-approved screening trial, with written informed consent, recruited female patients at e

167 Women aged 18-60 years who provided written informed consent, resided in the participating c

168 al review board approval and after obtaining written informed consent, SII examinations were performe

169 pective study in which all subjects provided written informed consent, six patients with relapsing-re

170 All subjects provided written informed consent; the study protocol was approve

171 With written informed consent, this institutional review boar

172 Participants provided written informed consent to a protocol that was approved

173 at elevated risk for breast cancer, who gave written informed consent to participate in a study evalu

174 Each subject gave written informed consent to participate in this institut

175 Study participants provided written informed consent to participate in this institut

176 6.6 years +/- 7.7 [standard deviation]) gave written informed consent to participate in this prospect

177 patients had no evidence of having provided written informed consent to participate.

178 as having dementia, and 634 (9.3%) provided written informed consent to participate.

179 Materials and Methods All participants gave written informed consent to undergo brain magnetic reson

180 years) with malignant liver lesions who gave written informed consent underwent preoperative gadoxeti

181 d by the institutional ethics committee, and written informed consent was acquired.

182 Written informed consent was obtained before enrollment.

183 Written informed consent was obtained for all enrolled s

184 Written informed consent was obtained for this ethics co

185 tional review board approved this study, and written informed consent was obtained from 25 symptomati

186 After institutional review board approval, written informed consent was obtained from 29 patients w

187 Written informed consent was obtained from 67 consecutiv

188 Written informed consent was obtained from all 80 patien

189 the National Research Ethical Committee, and written informed consent was obtained from all individua

190 h was approved by the local ethics board and written informed consent was obtained from all participa

191 roved by the institutional review board, and written informed consent was obtained from all participa

192 iew boards of all participating centers, and written informed consent was obtained from all participa

193 mmittee approved this prospective study, and written informed consent was obtained from all participa

194 Written informed consent was obtained from all participa

195 Written informed consent was obtained from all participa

196 approved by the local ethics committee, and written informed consent was obtained from all participa

197 Written informed consent was obtained from all participa

198 and institutional review board approval, and written informed consent was obtained from all participa

199 Written informed consent was obtained from all participa

200 Written informed consent was obtained from all participa

201 roved by the institutional review board, and written informed consent was obtained from all participa

202 Written informed consent was obtained from all participa

203 obtained from the Dutch Health Council, and written informed consent was obtained from all participa

204 +/- SD, 34.3 +/- 6.5 y) were recruited, and written informed consent was obtained from all participa

205 Written informed consent was obtained from all participa

206 s approved by the local ethics committee and written informed consent was obtained from all participa

207 approved by the local ethics committee, and written informed consent was obtained from all patients

208 Written informed consent was obtained from all patients

209 Written informed consent was obtained from all patients

210 Materials and Methods Written informed consent was obtained from all patients

211 Written informed consent was obtained from all patients,

212 Written informed consent was obtained from all patients,

213 Materials and Methods Written informed consent was obtained from all patients,

214 Written informed consent was obtained from all patients,

215 roved by the institutional review board, and written informed consent was obtained from all patients.

216 was approved by the ethics review board, and written informed consent was obtained from all patients.

217 approved by the local ethics committee, and written informed consent was obtained from all patients.

218 ved by the appropriate ethics committee, and written informed consent was obtained from all patients.

219 dy was approved by the ethics committee, and written informed consent was obtained from all patients.

220 Ethics Board, London, Ontario, Canada), and written informed consent was obtained from all patients.

221 iew boards of all participating centers, and written informed consent was obtained from all patients.

222 National Research Ethics Service Committee; written informed consent was obtained from all patients.

223 udy had institutional review board approval; written informed consent was obtained from all patients.

224 dy was approved by our ethics committee, and written informed consent was obtained from all patients.

225 approved by the local ethics committee, and written informed consent was obtained from all patients.

226 Written informed consent was obtained from all patients.

227 roved by the institutional review board, and written informed consent was obtained from all study par

228 had institutional review board approval, and written informed consent was obtained from all study par

229 approved by the local ethics committees, and written informed consent was obtained from all subjects

230 cal ethical committees on human studies, and written informed consent was obtained from all subjects

231 approved by the local ethical committee, and written informed consent was obtained from all subjects

232 Written informed consent was obtained from all subjects,

233 approved by the local ethical committee, and written informed consent was obtained from all subjects.

234 was obtained for this prospective study, and written informed consent was obtained from all subjects.

235 institutional review board at each site, and written informed consent was obtained from all subjects.

236 by the local institutional review board, and written informed consent was obtained from all subjects.

237 e multi-institutional HIPAA-compliant study; written informed consent was obtained from all subjects.

238 Written informed consent was obtained from all subjects.

239 er and Leiden University Medical Center, and written informed consent was obtained from all subjects.

240 erformed with ethical review board approval; written informed consent was obtained from all volunteer

241 Written informed consent was obtained from all volunteer

242 rom the John Radcliffe Hospital, Oxford, UK; written informed consent was obtained from each particip

243 approved by the local ethics committee, and written informed consent was obtained from each particip

244 approved by the local ethical committee, and written informed consent was obtained from each particip

245 Written informed consent was obtained from each particip

246 Written informed consent was obtained from each patient.

247 approved by the local ethics committee, and written informed consent was obtained from each patient.

248 Written informed consent was obtained from each subject.

249 approved by the institutional board review; written informed consent was obtained from healthy subje

250 Written informed consent was obtained from patients or t

251 roved by the institutional review board, and written informed consent was obtained from patients.

252 roved by the institutional review board, and written informed consent was obtained from the patient's

253 roved by the institutional review board, and written informed consent was obtained prior to inclusion

254 The vaccine was administered after written informed consent was obtained to complete a scre

255 ctive reading study (the TOMMY trial), after written informed consent was obtained, 8869 women (age r

256 Materials and Methods After written informed consent was obtained, 8869 women (age r

257 nal ethics committee approved the study, and written informed consent was obtained.

258 had institutional review board approval, and written informed consent was obtained.

259 was approved by the local ethics committee; written informed consent was obtained.

260 was approved by the local ethics committee; written informed consent was obtained.

261 according to the declaration of Helsinki and written informed consent was obtained.

262 was institutional review board approved, and written informed consent was obtained.

263 had institutional review board approval, and written informed consent was obtained.

264 eceived institutional review board approval; written informed consent was obtained.

265 otocol, and all patients were enrolled after written informed consent was obtained.

266 imaging datasets were acquired at 3 T after written informed consent was obtained.

267 d by age, and interviews occurred only after written informed consent was obtained.

268 ved by the institutional research board, and written informed consent was obtained.

269 Written informed consent was obtained.

270 roved by the institutional review board, and written informed consent was obtained.

271 oved by the institutional review boards, and written informed consent was obtained.

272 approved the prospective study protocol, and written informed consent was obtained.

273 by the local institutional review board, and written informed consent was provided by all patients at

274 Written informed consent was provided by all women who e

275 Written informed consent was waived because all the pati

276 Written informed consent was waived by the institutional

277 utional review board approved the study, and written informed consent was waived for patients and was

278 institutional review board, and the need for written informed consent was waived.

279 Requirement for written informed consent was waived.

280 approved by the local ethics committee, and written informed consent was waived.

281 Written informed consent was waived.

282 The requirement to obtain written informed consent was waived.

283 questions in English or siSwati, and provide written informed consent were eligible for the study.

284 e to access a telephone; and able to provide written informed consent were followed up for 2 years.

285 Patients scheduled for PD who gave written informed consent were included and randomized du

286 hods Institutional review board approval and written informed consent were obtained for the Effect of

287 Institutional review board approval and written informed consent were obtained for this HIPAA-co

288 Institutional review board approval and written informed consent were obtained for this HIPAA-co

289 Institutional review board approval and written informed consent were obtained for this HIPAA-co

290 itutional review board approval and parental written informed consent were obtained for this prospect

291 Institutional review board approval and written informed consent were obtained from all patients

292 hods Institutional review board approval and written informed consent were obtained from all subjects

293 roval of the institutional review boards and written informed consent were obtained from each partici

294 search ethics committee approval and patient written informed consent were obtained.

295 Institutional review board approval and written informed consent were obtained.

296 Local ethics committee approval and written informed consent were obtained.

297 Institutional review board and written informed consent were obtained.

298 hods Institutional review board approval and written informed consent were obtained.

299 oard and local ethics committee approval and written informed consent were obtained.

300 proved by the institutional review board and written informed consent with HIPAA authorization was ob